Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Velora Discover: A Prospective, Screening Study of Bleeding and Treatment in Participants With Von Willebrand Disease

NCT06610201 is registered in ClinicalTrials.gov with Hemab ApS as lead sponsor.

NCT NCT06610201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06610201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Velora Discover: A Prospective, Screening Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Lead sponsor
Hemab ApS
Phase
Observational
Overall status
Recruiting
Start date
August 30, 2024
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

von willebrand disease (vwd), von willebrand disease (vwd), type 1, von willebrand disease (vwd), type 2, von willebrand disease (vwd), type 3, von willebrand disease, type 2a, von willebrand disease, type 2m, von willebrand disease, type 2n